BMRN icon

BioMarin Pharmaceuticals

548 hedge funds and large institutions have $17.4B invested in BioMarin Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 205 increasing their positions, 185 reducing their positions, and 80 closing their positions.

Holders
548
Holders Change
-27
Holders Change %
-4.7%
% of All Funds
8.77%
Holding in Top 10
11
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-26.67%
% of All Funds
0.18%
New
61
Increased
205
Reduced
185
Closed
80
Calls
$238M
Puts
$123M
Net Calls
+$115M
Net Calls Change
+$46.3M
Name Market Value Shares Shares
Change
Shares
Change %
Primecap Management
1
Primecap Management
California
$1.77B 18,243,429 +662,570 +4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.7B 17,533,246 +168,166 +1%
BlackRock
3
BlackRock
New York
$1.42B 14,638,576 +98,385 +0.7%
Dodge & Cox
4
Dodge & Cox
California
$1.39B 14,329,313 -54,350 -0.4%
Capital Research Global Investors
5
Capital Research Global Investors
California
$701M 7,208,959 +1,557,958 +28%
State Street
6
State Street
Massachusetts
$590M 6,066,318 +677,474 +13%
Ameriprise
7
Ameriprise
Minnesota
$480M 4,938,346 +289,718 +6%
ACA
8
Avoro Capital Advisors
New York
$384M 3,945,000 +389,445 +11%
BBA
9
Baker Bros. Advisors
New York
$371M 3,810,248 -3,810,246 -50%
Bank of America
10
Bank of America
North Carolina
$342M 3,515,830 +2,370,416 +207%
Janus Henderson Group
11
Janus Henderson Group
United Kingdom
$334M 3,437,284 -451,160 -12%
Norges Bank
12
Norges Bank
Norway
$280M 2,884,483 +130,466 +5%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$258M 2,662,123 +78,019 +3%
JPMorgan Chase & Co
14
JPMorgan Chase & Co
New York
$248M 2,553,926 -6,718 -0.3%
Parnassus Investments
15
Parnassus Investments
California
$227M 2,338,529
Viking Global Investors
16
Viking Global Investors
Connecticut
$211M 2,168,617 -3,105,003 -59%
Deutsche Bank
17
Deutsche Bank
Germany
$204M 2,096,775 -291,991 -12%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$202M 2,079,649 +375,850 +22%
PAMS
19
Pictet Asset Management (Switzerland)
Switzerland
$200M 2,054,522 +576,001 +39%
PAI
20
Palo Alto Investors
California
$178M 1,831,035 -54,776 -3%
Invesco
21
Invesco
Georgia
$177M 1,817,010 -18,051 -1%
O
22
OrbiMed
New York
$157M 1,615,210
Barclays
23
Barclays
United Kingdom
$156M 1,604,826 -377,663 -19%
Northern Trust
24
Northern Trust
Illinois
$127M 1,305,438 +248 +0%
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
$126M 1,294,047 +366,211 +39%